[HTML][HTML] Tau deposition patterns are associated with functional connectivity in primary tauopathies
…, A Finze, C Palleis, E Joseph, E Weidinger… - Nature …, 2022 - nature.com
Tau pathology is the main driver of neuronal dysfunction in 4-repeat tauopathies, including
cortico-basal degeneration and progressive supranuclear palsy. Tau is assumed to spread …
cortico-basal degeneration and progressive supranuclear palsy. Tau is assumed to spread …
Loss of TREM2 rescues hyperactivation of microglia, but not lysosomal deficits and neurotoxicity in models of progranulin deficiency
Haploinsufficiency of the progranulin (PGRN)‐encoding gene (GRN) causes frontotemporal
lobar degeneration (GRN‐FTLD) and results in microglial hyperactivation, TREM2 activation…
lobar degeneration (GRN‐FTLD) and results in microglial hyperactivation, TREM2 activation…
Microglial activation and connectivity in Alzheimer disease and aging
Objective Alzheimer disease (AD) is characterized by amyloid β (Aβ) plaques and neurofibrillary
tau tangles, but increasing evidence suggests that neuroinflammation also plays a key …
tau tangles, but increasing evidence suggests that neuroinflammation also plays a key …
Cortical [18F]PI‐2620 Binding Differentiates Corticobasal Syndrome Subtypes
Background Corticobasal syndrome is associated with cerebral protein aggregates composed
of 4‐repeat (~50% of cases) or mixed 3‐repeat/4‐repeat tau isoforms (~25% of cases) or …
of 4‐repeat (~50% of cases) or mixed 3‐repeat/4‐repeat tau isoforms (~25% of cases) or …
In vivo assessment of neuroinflammation in 4‐repeat tauopathies
…, G Biechele, T Blume, Y Shi, E Weidinger… - Movement …, 2021 - Wiley Online Library
Background Neuroinflammation has received growing interest as a therapeutic target in
neurodegenerative disorders, including 4‐repeat tauopathies. Objectives The aim of this cross‐…
neurodegenerative disorders, including 4‐repeat tauopathies. Objectives The aim of this cross‐…
[HTML][HTML] Individual regional associations between Aβ-, tau-and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies
…, C Palleis, S Katzdobler, E Weidinger… - Molecular …, 2023 - nature.com
β-amyloid (Aβ) and tau aggregation as well as neuronal injury and atrophy (ATN) are the
major hallmarks of Alzheimer’s disease (AD), and biomarkers for these hallmarks have been …
major hallmarks of Alzheimer’s disease (AD), and biomarkers for these hallmarks have been …
[HTML][HTML] A unified classification approach rating clinical utility of protein biomarkers across neurologic diseases
A major evolution from purely clinical diagnoses to biomarker supported clinical diagnosing
has been occurring over the past years in neurology. High-throughput methods, such as next…
has been occurring over the past years in neurology. High-throughput methods, such as next…
[HTML][HTML] Additive value of [18F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome
…, M Song, O Wagemann, C Palleis, E Weidinger… - European journal of …, 2023 - Springer
Purpose Early after [ 18 F]PI-2620 PET tracer administration, perfusion imaging has potential
for regional assessment of neuronal injury in neurodegenerative diseases. This is while …
for regional assessment of neuronal injury in neurodegenerative diseases. This is while …
[HTML][HTML] Impact of TSPO Receptor Polymorphism on [18F]GE-180 Binding in Healthy Brain and Pseudo-Reference Regions of Neurooncological and …
…, S Lindner, BS Rauchmann, C Palleis, E Weidinger… - Life, 2021 - mdpi.com
TSPO-PET tracers are sensitive to a single-nucleotide polymorphism (rs6971-SNP),
resulting in low-, medium- and high-affinity binders (LABs, MABs and HABS), but the clinical …
resulting in low-, medium- and high-affinity binders (LABs, MABs and HABS), but the clinical …
[HTML][HTML] Dual-phase β-amyloid PET captures neuronal injury and amyloidosis in corticobasal syndrome
…, M Unterrainer, S Harris, C Prix, E Weidinger… - Frontiers in aging …, 2021 - frontiersin.org
Objectives: In recent years several 18 F-labeled amyloid PET (Aβ-PET) tracers have been
developed and have obtained clinical approval. There is evidence that Aβ-PET perfusion can …
developed and have obtained clinical approval. There is evidence that Aβ-PET perfusion can …